(Bloomberg) -- Bayer AG’s kidney drug Kerendia helped patients avoid complications from a common form of heart failure in ...
Bayer and Merck & Co’s heart failure drug vericiguat has been ... Armstrong, cardiologist and Distinguished University Professor of Medicine at the Canadian VIGOUR Centre, University of Alberta ...
A medication that is currently used for chronic ... In order for the drug to get FDA approval for use in these people with ...
Bayer's two-year-old digital health collaboration ... one-on-one coaching and heart health advice – all delivered and organised via an app. The first iteration of the software is aimed at ...
Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School ... available treatments in patients with HF LVEF =40%. “Bayer has a strong heritage in cardiology, and heart failure is a ...
Reprogrammed stem cells are being tested in at least 50 clinical trials around the globe, and the first approved therapy ...
The DSO model is not just a structural adjustment; it's a strategic realignment aimed at enhancing Bayer's agility and responsiveness to market demands. At the heart of DSO is the reduction of ...
Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The ...
Precision for Medicine has hired Margaret Keegan as Chief Executive Officer ... The company’s cuts are effective December 27. Bayer also announced a round of layoffs from its Whippany, New Jersey ...
Bayer Ag BAYRY and its wholly owned subsidiary BlueRock Therapeutics LP announced positive 24-month data from an early-stage study on experimental candidate bemdaneprocel (BRT-DA01). Bemdaneprocel ...
Heart transplantation dramatically improves ... of innovative treatments to enhance regenerative medicine strategies. For example, Bayer researchers are developing gene circuits to precisely ...
The 31-year-old sustained an ankle injury during Saturday’s 1-1 draw with Bayer Leverkusen following a collision. He was forced off after 86 minutes having received treatment on the pitch.